Levodopa

FDA rejects Amneal’s Parkinson’s drug, $500M peak sales goal unattainable

Source – Amneal Pharmaceuticals On July 3, 2023, Amneal Pharmaceuticals’ plans to launch its extended-release Parkinson’s disease treatment, IPX203, by ...